OS Therapies Inc’s Quiet Period To End Tomorrow (NYSE:OSTX)

OS Therapies’ (NYSE:OSTX) quiet period is set to end on Tuesday, September 10th. OS Therapies had issued 1,600,000 shares in its IPO on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. During OS Therapies’ quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on OSTX shares. Brookline Capital Management raised shares of OS Therapies to a “strong-buy” rating in a report on Thursday, August 22nd. EF Hutton Acquisition Co. I upgraded shares of OS Therapies to a “strong-buy” rating in a research report on Tuesday, September 3rd.

OS Therapies Trading Up 4.5 %

NYSE OSTX opened at $4.18 on Monday. OS Therapies has a twelve month low of $2.51 and a twelve month high of $4.90.

OS Therapies (NYSE:OSTX) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.26) earnings per share for the quarter. On average, equities analysts expect that OS Therapies will post -0.47 earnings per share for the current fiscal year.

OS Therapies Company Profile

OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults.